SEC Form SC 13D/A filed by Catalyst Biosciences Inc. (Amendment)
CATALYST BIOSCIENCES, INC. |
(Name of Issuer) |
Common Stock, par value $0.001 |
(Title of Class of Securities) |
14888D208 |
(CUSIP Number) |
October 27, 2023 |
(Date of Event Which Requires Filing of this Statement) |
CUSIP No. 14888D208
|
||||
1.
|
Names of Reporting Persons
|
GNI Group Ltd.
|
||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) ☐
(b) ☐
|
||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions)
|
OO
|
||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
☐ | ||
6.
|
Citizenship or Place of Organization
|
Japan
|
||
Number of Shares Beneficially by Owned by Each Reporting Person With
|
7.
|
Sole Voting Power
|
6,266,521
|
|
8.
|
Shared Voting Power
|
0
|
||
9.
|
Sole Dispositive Power
|
6,266,521
|
||
10.
|
Shared Dispositive Power
|
0
|
||
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
6,266,521
|
||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
☐ | ||
13.
|
Percent of Class Represented by Amount in Row (11)
|
16.50%(1)
|
||
14.
|
Type of Reporting Person (See Instructions)
|
CO
|
CUSIP No. 14888D208
|
||||
1.
|
Names of Reporting Persons
|
GNI Hong Kong Limited
|
||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) ☐
(b) ☐
|
||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions)
|
OO
|
||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
☐
|
||
6.
|
Citizenship or Place of Organization
|
Hong Kong
|
||
Number of Shares Beneficially by Owned by Each Reporting Person With
|
7.
|
Sole Voting Power
|
0
|
|
8.
|
Shared Voting Power
|
0
|
||
9.
|
Sole Dispositive Power
|
0
|
||
10.
|
Shared Dispositive Power
|
0
|
||
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
0
|
||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
☐ | ||
13.
|
Percent of Class Represented by Amount in Row (11)
|
0%(1)
|
||
14.
|
Type of Reporting Person (See Instructions)
|
CO
|
CUSIP No. 14888D208
|
||||
1.
|
Names of Reporting Persons
|
GNI USA, Inc.
|
||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) ☐
(b) ☐
|
||
3.
|
SEC Use Only
|
|||
4.
|
Source of Funds (See Instructions)
|
OO
|
||
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
☐
|
||
6.
|
Citizenship or Place of Organization
|
Delaware
|
||
Number of Shares Beneficially by Owned by Each Reporting Person With
|
7.
|
Sole Voting Power |
0
|
|
8.
|
Shared Voting Power
|
6,266,521
|
||
9.
|
Sole Dispositive Power |
0
|
||
10.
|
Shared Dispositive Power
|
6,266,521
|
||
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
6,266,521
|
||
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
☐
|
||
13.
|
Percent of Class Represented by Amount in Row (11)
|
16.50%(1)
|
||
14.
|
Type of Reporting Person (See Instructions)
|
CO
|
a. |
This Schedule 13D is being filed by GNI Group Ltd., a company incorporated under the laws of Japan with limited liability (“GNI Japan”), GNI Hong Kong Limited, a company incorporated under the laws of Hong Kong with limited liability (“GNI
Hong Kong”) and GNI USA, Inc., a Delaware corporation (“GNI USA” and, together with GNI Japan and GNI Hong Kong, the “Reporting Persons”).
|
b. |
The principal business address of GNI USA is 12730 High Bluff Drive, Suite 250, San Diego, CA 92130.
|
c. |
GNI USA is a wholly-owned subsidiary of GNI Japan.
|
e. |
Effective as of October 27, 2023, GNI Hong Kong ceased to be the beneficial owner of more than five percent of the shares of Common Stock.
|
Dated: October 30, 2023
|
GNI Group Ltd.
/s/ Thomas Eastling
By:
Thomas Eastling
Its:
Attorney-in-fact
|
Dated: October 30, 2023 |
GNI Hong Kong Limited /s/ Thomas Eastling
By:
Thomas Eastling
Its:
Attorney-in-fact
|
Dated: October 30, 2023
|
GNI USA, Inc.
/s/ Thomas Eastling
By:
Thomas Eastling
Its:
Director
|
Name and Position
|
Business Office Address
|
Present Principal Occupation
|
||
Ying Luo, Ph.D.
|
Nihonbashi-Honcho YS Bldg. 3rd Floor
2-2-2 Nihonbashi-Honcho, Chuo-ku
103-0023 Tokyo, Japan
|
Director, President and Chief Executive Officer
|
||
Thomas Eastling |
12730 High Bluff Drive
Suite 250
San Diego, CA 92130
|
Director, Treasurer and Secretary
|